Home » Accelerated landing of international medical beauty strategy Huadong Medicine (000963.SZ) The global exclusive “Girls Needle” officially landed in the domestic market_stock channel_securities star

Accelerated landing of international medical beauty strategy Huadong Medicine (000963.SZ) The global exclusive “Girls Needle” officially landed in the domestic market_stock channel_securities star

by admin

(Original title: Accelerated landing of international medical beauty strategy Huadong Medicine (000963.SZ), the world’s exclusive “Girl Injection” officially landed in the domestic market)

On August 29, Sinclair, a wholly-owned subsidiary of Huadong Medicine (000963.SZ), announced at the new product launch conference that the company’s blockbuster product Ellansé has officially landed in the Chinese mainland market.

At the press conference, Mr. Kamal Abbasi, CEO of Sinclair Aesthetics Greater China, said: “Sincolae Aesthetics was born in the UK in 1979 and has nearly 50 years of profound scientific research. Ellansé was listed in Europe in 2009, and currently it It has been used safely in more than 60 countries and regions around the world for 12 years, and is deeply trusted and loved by experts and consumers around the world. In April this year, Ellansé became the first medical device to obtain the NMPA III medical device certification from the China Food and Drug Administration Imported renewable fillers.”

Clinical studies have shown that after the global aesthetic improvement standard GAIS, the effective rate after using Ellansé for 12 months is 90% and the effective rate for 24 months is 78%. 94% of the beauty seekers said the effect is very natural and practical. Feel the advantages of instant filling, long-term maintenance, and natural metabolism. In addition, millions of cigarettes worldwide have clinically proven that the adverse reaction rate after using Ellansé is extremely low.

Huadong Medicine stated that before the official listing of Ellansé, the company has successively carried out a series of preparations. The company established a wholly-owned subsidiary, Xinkeli Aesthetics (Shanghai) Medical Technology Co., Ltd. to be responsible for the sales and promotion of this product. At the same time, the company has equipped a full-time brand manager and established an independent direct sales team for Yiyanshi products, and related preparations such as brand and market communication, first medical beauty institutions and doctor training and education are also carried out as planned.

See also  Claudia Obert reveals how much money she has in her six accounts

In addition, on August 15th, Huadong Medicine held the first batch of injection physician training & certification meetings, theoretical teaching and practical experience, to effectively improve the professional skills of practitioners, and is committed to formulating personality for those seeking beauty in each treatment. Evaluate the aesthetics and design the injection plan, so that those who seek beauty can achieve a better plastic beauty experience.

It is reported that after the listing of Ellansé Yiyanshi, the number of first hospitals reached 100, and it will gradually expand to 300-500 hospitals next year. According to the announcement of Huadong Medicine’s 2021 semi-annual report, 2021H1 medical beauty business achieved revenue of 565 million yuan (+46.25%), of which international medical beauty business revenue was 276 million yuan, a year-on-year increase of 111.28%. Many securities firm research institutions believe that Ellansé Yiyanshi The launch of new products is expected to drive the company’s medical aesthetics business to usher in new performance growth.

The research report of China International Finance Securities pointed out that the current global medical beauty market has entered a period of stable development. It is conservatively estimated that the global medical beauty market will grow from US$135.7 billion in 2018 to US$178.2 billion in 2022, representing a CAGR of 7.5%; It is in a stage of high-growth development. The market size in 2020 is close to 200 billion yuan. It is estimated that the market size is expected to exceed 311.5 billion yuan by 2023, with a CAGR of 15.2%. In particular, light medical beauty has gradually become the choice of more and more young people.

See also  Prodi for Schlein, Letta-Bonaccini. Pd primaries, shocking indiscretion

With the gradual expansion of the market size, the supervision of the medical beauty industry is gradually strengthening. In May 2021, the National Health Commission and other eight ministries and commissions issued the “Special Remediation Work Plan for Combating Illegal Medical Beauty Services” to jointly launch a special remediation work against illegal medical beauty services.

Huadong Medicine believes that the country’s vigorous efforts to rectify and standardize the medical aesthetics industry will help eliminate illegal medical aesthetics institutions, accelerate industry clearance, and increase the market share and industry concentration of legal institutions. Huadong Medicine adheres to the high-end route, and builds a globalized medical aesthetics strategy with its own high-tech and high value-added medical aesthetics products as the core. As a traditional veteran pharmaceutical company, Huadong Medicine has always been deeply involved in the medical aesthetics industry with the scientific and rigorous attitude of pharmaceutical professionals. The registration and production of medical aesthetics products are strictly in accordance with relevant national regulations to promote the standardized development of the medical aesthetics industry.

According to the plan of Huadong Medicine, its medical aesthetics business will continue to adopt the strategy of “global operation layout, dual-cycle operation and development”, strengthen the international business expansion with Sinclair, a wholly-owned subsidiary of the United Kingdom, as the global medical aesthetics operation center, and in the domestic medical aesthetics industry Under the background of rapid development, the international first-class medical aesthetic products with high technological gold content are successively introduced into the country, adhere to the self-operated model, and rely on professional clinical registration and marketing promotion teams to help the company’s international high-quality products to quickly land and commercialize change.

See also  Ruby: "Crazy or prostitute, Silvio I can be everything for you. Lies about Ronaldo"

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy